Notable Labs Other Current Assets 2013-2024 | NTBLQ

Notable Labs other current assets from 2013 to 2024. Other current assets can be defined as field containing the sum of all current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
Notable Labs Annual Other Current Assets
(Millions of US $)
2023 $4
2022 $1
2021 $2
2020 $1
2019 $1
2018 $1
2017 $2
2016 $1
2015 $1
2014 $1
2013 $1
2012 $
Notable Labs Quarterly Other Current Assets
(Millions of US $)
2024-06-30 $3
2024-03-31 $4
2023-12-31 $4
2023-09-30 $0
2023-06-30 $0
2023-03-31 $1
2022-12-31 $1
2022-09-30 $0
2022-06-30 $2
2022-03-31 $2
2021-12-31 $2
2021-09-30 $1
2021-06-30 $1
2021-03-31 $1
2020-12-31 $1
2020-09-30 $1
2020-06-30 $2
2020-03-31 $1
2019-12-31 $1
2019-09-30 $2
2019-06-30 $1
2019-03-31 $1
2018-12-31 $1
2018-09-30 $1
2018-06-30 $2
2018-03-31 $2
2017-12-31 $2
2017-09-30 $1
2017-06-30 $4
2017-03-31 $2
2016-12-31 $1
2016-09-30 $1
2016-06-30 $1
2016-03-31 $1
2015-12-31 $1
2015-09-30 $1
2015-06-30 $1
2015-03-31 $1
2014-12-31 $1
2014-09-30 $4
2014-06-30
2014-03-31
2013-12-31 $1
2013-09-30
2012-12-31
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $0.000B $0.000B
Notable Labs Ltd. is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Notable Labs Ltd., formerly known as Vascular Biogenics Ltd., is based in FOSTER CITY, Calif.
Stock Name Country Market Cap PE Ratio
Fanhua (AIFU) China $0.086B 2.07
Top KingWin (WAI) China $0.008B 0.00
S&W Seed (SANW) United States $0.006B 0.00
Invo BioScience (NAYA) United States $0.004B 0.00
Ocuphire Pharma (IRD) $0.000B 0.00